TAMs originate from circulating monocyte precursors that are recruited to the tumor by tumor-derived signals, including chemokine (C-C motif) ligand 2 (CCL2) and macrophage colony-stimulating factor (M-CSF). Here, CCL2 is linked to neoplasm.